Sarcoidosis: can tofacitinib slay the dragon?

Nat Rev Rheumatol. 2022 Oct;18(10):557-558. doi: 10.1038/s41584-022-00832-1.
No abstract available

Publication types

  • Comment

MeSH terms

  • Humans
  • Menthol
  • Piperidines / therapeutic use
  • Pyrimidines / adverse effects
  • Sarcoidosis* / drug therapy

Substances

  • Piperidines
  • Pyrimidines
  • Menthol
  • tofacitinib